MET/HGF Coexpression as a Novel Predictive Biomarker for Response to MET Inhibitor Therapy in a Case of Psammomatous Melanotic Schwannoma

JCO Precis Oncol. 2022 Jun:6:e2200096. doi: 10.1200/PO.22.00096.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Hepatocyte Growth Factor
  • Humans
  • Neurilemmoma* / drug therapy

Substances

  • Biomarkers
  • HGF protein, human
  • Hepatocyte Growth Factor